Cointime

New Health Sciences

company

About

New Health Sciences develops a technology to extend the shelf life of refrigerated red blood cells using novel storage methods.

  • 11 - 50

Highlights

Total Funding Amount
$2.70M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$2.70M
Industries
Biopharma,Health Care,Life Science
Founded date
Jan 1, 2000
Number Of Employee
11 - 50
Operating Status
Active

New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods potentially extending the shelf life of refrigerated red blood cells while improving their quality across the storage cycle. NHSi has financed development of the Hemanext technology through private investor funding and a series of NIH SBIR grants.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$2.70M
New Health Sciences has raised a total of $2.70M in funding over 2 rounds. Their latest funding was raised on Dec 20, 2017 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 20, 2017 Series Unknown $2.70M 1 National Institutes of Health — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
New Health Sciences is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Series Unknown
Cointime
เนื้อหา
บริษัท